Author:
Mascaux C,Iannino N,Martin B,Paesmans M,Berghmans T,Dusart M,Haller A,Lothaire P,Meert A-P,Noel S,Lafitte J-J,Sculier J-P
Publisher
Springer Science and Business Media LLC
Reference71 articles.
1. Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D (2002) Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. J Thorac Cardiovasc Surg 123: 466–473
2. Andjelic G, Magic Z, Bokun R, Stepic V (2001) Mutations in K-Ras oncogene and their influence on survival of patients with non-small cell lung cancer. J BUON 6: 61–66
3. Broermann P, Junker K, Brandt BH, Heinecke A, Freitag L, Klinke F, Berdel WE, Thomas M (2002) Trimodality treatment in Stage III nonsmall cell lung carcinoma: prognostic impact of K-ras mutations after neoadjuvant therapy. Cancer 94: 2055–2062
4. Cho JY, Kim JH, Lee YH, Chung KY, Kim SK, Gong SJ, You NC, Chung HC, Roh JK, Kim BS (1997) Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer 79: 462–467
5. De Gregorio L, Manenti G, Incarbone M, Pilotti S, Pastorino U, Pierotti MA, Dragani TA (1998) Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma. Int J Cancer 79: 269–272
Cited by
524 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献